Figure 4.
(A) Number of findings and (B) incidences of HPV types that are impaired directly by vaccination or potentially via cross-protection by available vaccines. Participants <30 years of age are divided into two subgroups (group 1, <23 years old; group 2, 23–29 years old), where women ≤22 years old are more often protected against certain HPV types by vaccination, compared with participants aged >23 years old. HPV, human papilloma virus.